Literature DB >> 1725362

Subepicardial microischemia formation induced by epicardial application of endothelin-1.

S Hori1, S Kyotani, S Inoue, K Fukuda, Y Ohnishi, M Kusuhara, N Aikawa, K Yamaguchi, Y Nakamura, S Handa.   

Abstract

The effects of endothelin-1 (ET-1), applied topically on the epicardium, on the coronary microcirculation of the beating canine heart were investigated in situ. ET-1 (1, 10, 100, and 1,000 pmol) induced a dose-dependent elevation of the ST segment in the epicardial ECG (n = 5). After application of ET-1 (100 pmol), the beating hearts were rapidly cross-sectioned and freeze-clamped in 120 ms using a specially developed device (n = 6). By NADH fluorescence photography of the cross-sectioned frozen sample, an increased fluorescent area in the subepicardium was clearly observable. The fluorescent dye injected from the left atrium was negative in the NADH fluorescent area. It can be concluded that ET-1, when administered extravascularly, induces severe vasoconstriction and myocardial ischemia in the microcirculation of the beating canine heart.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725362     DOI: 10.1097/00005344-199100177-00085

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

Review 1.  Congenital pericardial defect: report of two cases and literature review.

Authors:  M Montaudon; F Roubertie; F Bire; F Laurent
Journal:  Surg Radiol Anat       Date:  2007-03-22       Impact factor: 1.246

2.  Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.

Authors:  V Richard; N Kaeffer; M Hogie; C Tron; T Blanc; C Thuillez
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

Review 3.  [Pneumonectomy for Non-small Cell Lung Cancer: Predictors of Operative Mortality and Survival].

Authors:  Xiaokang Guo; Huafeng Wang; Yucheng Wei
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.